>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 20, 2013

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance

Summary:

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

ASA to Congressional Negotiators: Now is the Time to Repeal SGR and IPAB

Friday, February 10, 2012

As Congress continues its deliberations on the Medicare Sustainable Growth Rate (SGR) and other issues related to H.R. 3630, the Temporary Payroll Tax Cut Continuation Act of 2011, ASA re-affirmed the specialty’s strong support for a full repeal of SGR.  ASA urged that the SGR be replaced with a new payment model that takes into account the specialty’s unique historical payment disparity known as the “33% problem.”  ASA further advocated tying the payment fixes to the immediate repeal of the Independent Payment Advisory Board (IPAB)—an unaccountable and unelected board created under the Patient Protection and Affordable Care Act with sweeping powers to mandate Medicare payment cuts.

To read the entire letter, click here

« Back to Washington Alerts